Estimating influenza vaccine efficacy from challenge and community-based study data - Wikidata - thesis-toulmin - TriplyDB

Estimating influenza vaccine efficacy from challenge and community-based study data

Estimating influenza vaccine efficacy from challenge and community-based study data

http://www.wikidata.org/entity/Q24655781

about

The global transmission and control of influenza Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic.Protecting health care workers: a pandemic simulation based on Allegheny County FluTE, a publicly available stochastic influenza epidemic simulation model Seasonal influenza vaccination and technologies.Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.The transmissibility and control of pandemic influenza A (H1N1) virus.One versus two doses: What is the best use of vaccine in an influenza pandemic?A computer simulation of employee vaccination to mitigate an influenza epidemic.Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model.Canada in the face of the 2009 H1N1 pandemic.Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.Reconstructing the 2003/2004 H3N2 influenza epidemic in Switzerland with a spatially explicit, individual-based model.Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza.Critical immune and vaccination thresholds for determining multiple influenza epidemic waves.Modeling vaccination campaigns and the Fall/Winter 2009 activity of the new A(H1N1) influenza in the Northern Hemisphere.Real-time numerical forecast of global epidemic spreading: case study of 2009 A/H1N1pdm.Optimal vaccine allocation for the early mitigation of pandemic influenza.Projection of seasonal influenza severity from sequence and serological data Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.The impact of model building on the transmission dynamics under vaccination: observable (symptom-based) versus unobservable (contagiousness-dependent) approaches.Positive network assortativity of influenza vaccination at a high school: implications for outbreak risk and herd immunity.Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014.Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community Vaccination and clinical severity: is the effectiveness of contact tracing and case isolation hampered by past vaccination?Characteristics of vaccine failures in a randomized placebo-controlled trial of inactivated influenza vaccine in children.Reply to "Studies on influenza virus transmission between ferrets: the public health risks revisited".Effects of vaccination against pandemic (H1N1) 2009 among Japanese children.Health-care worker vaccination for influenza: strategies and controversies.Unraveling R0: considerations for public health applications.

P2860

Q27342983-06539964-DB01-4111-BC7A-BD265B144206 Q30226721-EF72944F-A871-45AA-B9E2-D5A2300287D4 Q30227160-1935FABC-FF7F-470C-B22F-BF76438793AD Q30227291-8FF8FF41-3F19-4687-A707-8AB7C5746285 Q30227314-2894FC31-4DB4-41BC-BAEA-663F268E1047 Q30360897-F2289FC3-6E44-4663-BAB0-E7917A58721F Q30375714-2BEE74D2-5AF3-48F2-BBEF-9714B2F457AF Q30379858-E0A8CB0C-1176-41D8-AAAE-F855043ADF64 Q30380569-464AB98F-025C-4325-9127-CF88A625378B Q30382026-F6872F37-86DB-4C0B-B95E-4721B01C6D9C Q30383984-C2991B1D-EABA-45B2-83F5-E22A6E9430DB Q30389700-F287C4B3-C06D-4E79-8309-CA2704B074DD Q30398939-9E4B7B74-6F7F-4A6E-B23F-720B463A36BC Q30399492-F9864051-12A5-47BE-8592-C07BD221699D Q30400623-9AAEFF1A-2818-4048-B92A-0D5EBBCC4582 Q30402450-8ACBA382-3B25-4E77-B809-8F0D81B9A54D Q30403057-F57C1D34-8894-4A80-9A4C-5ACACB5381A9 Q30412892-202CC0FC-8A7C-4C17-9B86-2B56D985E8C5 Q30412913-D149A5DF-F5EE-4DFC-8FF2-5A64636EEBBC Q30414759-244E5366-61EA-45C3-BAC3-74DC0F2DAF31 Q30424718-5C606F31-8B93-4B5F-BCE3-768C53BC63B3 Q30428994-DADE6BCF-6CB8-4E49-8DB9-557383122EDA Q33769997-8BE2AFD3-93FC-45EE-B216-C25B47CBC94B Q34333245-E5BF4041-AB05-49CD-AFD1-3C6346C55C5B Q34613417-673349F9-6934-4183-B535-76140294D02B Q34675056-D4954126-24E8-46B5-A775-82403397FA37 Q35088115-50AB4C2E-57CC-4E95-861D-8815083A3849 Q35500457-4E256C0F-A376-4219-9F94-E1353570BB3A Q36615123-A867C421-CBC5-4DC6-A20E-271EC910CC5C Q37005541-1B70461F-5215-4E07-B054-DBAB08984DBD Q37625970-F8052EDC-AA0B-45D0-A62A-0EC7155F1055 Q43141648-DA4656EC-92D0-4125-857D-56099596E69C Q43173045-3A78BC9B-9C98-4027-98D2-C6A423E8DB48 Q44978409-E760F01D-57E8-423F-91F5-8302928E7B6A Q51767340-27EC91C7-8187-4080-BB1A-5269A4CC2FD9

P2860

Estimating influenza vaccine efficacy from challenge and community-based study data

http://www.wikidata.org/entity/Q24655781

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Estimating influenza vaccine efficacy from challenge and community-based study data

@ast

Estimating influenza vaccine efficacy from challenge and community-based study data

@en

Estimating influenza vaccine efficacy from challenge and community-based study data

@nl

type

label

Estimating influenza vaccine efficacy from challenge and community-based study data

@ast

Estimating influenza vaccine efficacy from challenge and community-based study data

@en

Estimating influenza vaccine efficacy from challenge and community-based study data

@nl

prefLabel

Estimating influenza vaccine efficacy from challenge and community-based study data

@ast

Estimating influenza vaccine efficacy from challenge and community-based study data

@en

Estimating influenza vaccine efficacy from challenge and community-based study data

@nl

P1433

Q24655781-E14C9838-D006-41DB-BE5D-70656A1C8195

P1476

Q24655781-184490BF-9BA5-402D-BFF5-90B7B72C69CB

P2093

Q24655781-5EC91E8F-4EE5-4D8D-919A-06BA240AC116

Q24655781-AA9E23FE-4CB4-4BD0-97A9-C27F8D998808

P275

Q24655781-050D8109-2A66-4009-8D11-396DD4E369F4

P2860

Q24655781-0A34C6CB-D849-490D-9C4F-43012983E6AE

Q24655781-2F772AA6-C9A4-496F-96A4-9D72DDE069D6

Q24655781-359FDE92-A6F0-4D83-9E4D-349D3731B64B

Q24655781-5609EA85-193F-4B0E-BA94-04D80D88B953

Q24655781-7295DEE6-40A6-4036-9BDC-6FD09CD4AB29

Q24655781-7C840734-4970-40EB-A60B-ABCF1ABEF6A1

Q24655781-7E62D3CD-7ECB-4781-A24D-C2D780B7C9E0

Q24655781-7F7CB8D0-381F-4441-9E37-F60763BF98BC

Q24655781-82D4FAD0-F527-49C2-BBEC-8B7C9784C48E

Q24655781-90A95D2B-01BE-4438-A37F-C7D508304C64

P304

Q24655781-1CD9281D-0D7A-449E-8F88-4FD2E59C77B2

P31

Q24655781-7A0D079D-C5E5-48AB-9015-ED472EE47260

Q24655781-A63877B2-E9F0-4161-8D16-F21F4B3C5BF4

P3181

Q24655781-1A8FA612-932B-44D8-9506-B5D8FFA86254

P356

Q24655781-A4BCC328-7DC4-4A3D-9A32-5D73E0937691

P407

Q24655781-90FA15C8-BC51-4E8C-9E6C-94339ABB860C

P433

Q24655781-14FFAF33-1576-4C01-9696-3B48582269E2

P478

Q24655781-6424DFB8-DAAD-4D6F-974B-0ECCD08365A8

P50

Q24655781-6CFEDCAB-E972-4C63-B5C6-E06D6520D03C

Q24655781-79889231-602B-4D60-A0B6-C52BDE092930

P5008

Q24655781-F2AFA1C9-A963-4844-B83E-41BE0BACD7DC

P577

Q24655781-95B09BA9-AC31-4C8E-97C5-97140C184E01

P5875

Q24655781-A0AEA3A2-7ACF-4694-92DA-52D89E871048

P698

Q24655781-20C77DDB-6579-4C85-ADA1-313CCC8C7A7D

P921

Q24655781-01AC4A23-CC76-4C6B-B7EB-21661A396F43

P932

Q24655781-DDB61544-47BA-4E54-B42C-F623106314CE

P3181

P356

P1433

American Journal of Epidemiology

P1476

Estimating influenza vaccine efficacy from challenge and community-based study data

@en

P2093

Laura Matrajt

http://www.w3.org/2001/XMLSchema#string

Nicole E Basta

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Containing pandemic influenza with antiviral agents.

Containing pandemic influenza at the source.

Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004

An influenza simulation model for immunization studies.

Design and interpretation of vaccine field studies.

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

Time lines of infection and disease in human influenza: a review of volunteer challenge studies.

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines

Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine.

P304

1343-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

540466

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/AJE/KWN259

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2008-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23441660

http://www.w3.org/2001/XMLSchema#string

P698

18974084

http://www.w3.org/2001/XMLSchema#string

P921

P932

2638553

http://www.w3.org/2001/XMLSchema#string